| 中文名称: | 牛磺脱氧胆酸钠水合物 促销 | ||||
|---|---|---|---|---|---|
| 英文名称: | Sodium taurodeoxycholate hydrate | ||||
| 别名: | 牛磺脱氧胆酸钠水合物 2-([3α,12α-Dihydroxy-24-oxo-5β-cholan-24-yl]amino)ethanesulfonic acid | ||||
| CAS No: | 207737-97-1 | 分子式: | C26H44NNaO6S.XH2O | 分子量: | 521.69 |
| CAS No: | 207737-97-1 | ||||
| 分子式: | C26H44NNaO6S.XH2O | ||||
| 分子量: | 521.69 | ||||
| MDL: | MFCD00149238 | ||||
熔点：
168°C
包装规格：
1g 5g 25g 100g in poly bottle
产品简介：
一种胆汁盐相关的阴离子洗涤剂，用于分离膜蛋白，包括线粒体内膜膜蛋白。
溶解性：
溶于水 (100 mg/ml)
储备液保存：
-80°C, 6 months
-20°C, 1 month
-20°C, 1 month
靶点：
Microbial Metabolite
体外研究：
The median plasma concentration of Taurodeoxycholate is 33.9 nM in healthy individuals.
Taurodeoxycholate inhibits the binding of N-3H-methylscopolamine to the M3 muscarinic receptor of acetylcholine with an IC50 of 170 µM.
Taurodeoxycholate (0.05-1.00 mM; 1-6 days) stimulates intestinal epithelial cell proliferation.
Taurodeoxycholate (0.05-1.00 mM; 24 h) induces a significant increase in S-phase concentration and a significant decrease in G1-phase concentration of the cell cycle, increases c-myc protein and mRNA expression in IEC-6 cells.
Taurodeoxycholate inhibits the binding of N-3H-methylscopolamine to the M3 muscarinic receptor of acetylcholine with an IC50 of 170 µM.
Taurodeoxycholate (0.05-1.00 mM; 1-6 days) stimulates intestinal epithelial cell proliferation.
Taurodeoxycholate (0.05-1.00 mM; 24 h) induces a significant increase in S-phase concentration and a significant decrease in G1-phase concentration of the cell cycle, increases c-myc protein and mRNA expression in IEC-6 cells.
体内研究：
Taurodeoxycholate (0.5 mg/kg; i.v.; once) confers protection to C57BL/6N mice with sepsis, but does not protect TGR5 KO mice under sepsis.
保存条件：
室温
UN码：
HazardClass：
危害声明：
安全说明：
搜索质检报告(COA)
参考文献 & 客户发表文献
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为：
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液，使用的计算公式为：
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为：C1V1 = C2V2 ( 输入 输出 )
